fluoxetine has been researched along with Cardiometabolic Syndrome in 4 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SY | 1 |
| Chen, SL | 1 |
| Chang, YH | 1 |
| Chen, PS | 1 |
| Huang, SY | 2 |
| Tzeng, NS | 2 |
| Wang, CL | 1 |
| Wang, LJ | 1 |
| Lee, IH | 1 |
| Wang, TY | 1 |
| Chen, KC | 1 |
| Yang, YK | 1 |
| Hong, JS | 1 |
| Lu, RB | 2 |
| De Long, NE | 1 |
| Barry, EJ | 1 |
| Pinelli, C | 1 |
| Wood, GA | 1 |
| Hardy, DB | 1 |
| Morrison, KM | 1 |
| Taylor, VH | 1 |
| Gerstein, HC | 1 |
| Holloway, AC | 1 |
| Hung Chi, M | 1 |
| Hua Chang, H | 1 |
| Chou, KR | 1 |
| Chun Tsai, H | 1 |
| Kuang Yang, Y | 1 |
| See Chen, P | 1 |
| Aylwin, S | 1 |
| Al-Zaman, Y | 1 |
1 review available for fluoxetine and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Baria | 2008 |
1 trial available for fluoxetine and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Correlation of plasma brain-derived neurotrophic factor and metabolic profiles in drug-naïve patients with bipolar II disorder after a twelve-week pharmacological intervention.
Topics: Adult; Affect; Bipolar Disorder; Body Mass Index; Brain-Derived Neurotrophic Factor; Cholesterol; Fe | 2015 |
2 other studies available for fluoxetine and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats.
Topics: Adiposity; Animals; Blood Glucose; Chemical and Drug Induced Liver Injury; Chemokine CCL2; Diabetes | 2015 |
The prevalence of metabolic syndrome in drug-naïve bipolar II disorder patients before and after twelve week pharmacological intervention.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Body Mass Index; Diagnostic and Statistical Manual of Men | 2013 |